European Society of Toxicology In Vitro > Uncategorized > ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026
20 February 2026

ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026

Are you attending SOT? Will you be in San Diego on March 22?

The Physicians Committee for Responsible Medicine and Qureator are hosting a FREE in-person workshop and lab tour on March 22 ahead of the SOT kickoff. Qureator is a biotechnology company recently shortlisted for the Lush Science Prize. They are transforming the drug discovery process with their vascularized organoid technology that has been used to secure FDA IND approval without animal proof-of-concept data.


Date: March 22, 2026
Time: 9:30 am – 12:00 pm ET / 14:30 – 17:00 UTC

In this workshop, participants will gain first-hand experience with next-generation preclinical validation using Qureator’s human-derived vascularized organoids, tour the facility, and hear from scientists working with the models and leaders working to advance human-specific non-animal approaches. Transportation to and from the San Diego Convention Center (SOT venue) and lunch will be provided. 

REGISTER NOW

This event is limited to 20 participants, and registration is required.

Complete details are also available on the Event Calendar Listing.
Recordings and other materials from this webinar will be posted to the ASCCT Webinar Archive.
Information on additional upcoming webinars and other events is available on the ASCCT Event Calendar.

Related content

In Memory of Dr. Alan M. Goldberg (1939–2026)

The European Society of Toxicology In Vitro (ESTIV) joins the international scientific community in mourning the loss of Dr. Alan M. Goldberg, who passed away on 9 June 2026 at the age of 86.

The ESTIV congress – A journey that began before ESTIV itself…from Soesterberg to Maastricht

As we prepare for the 23rd ESTIV Congress in Maastricht in 2026, we found ourselves looking back at the remarkable history of our community.
Many people know that the European Society of Toxicology In Vitro (ESTIV) was formally established in 1994. What is less widely known is that the roots of ESTIV go much deeper.

Connecting early-career Researchers: ASPIS Academy, PARC Junior Community, and VICT3R ESR network

This interactive session, brings together early-career researcher communities from three major European initiatives in toxicology and chemical safety: the ASPIS Academy, the PARC Junior Community, and the VICT3R Early Stage Researcher Network.

Silver Sponsor

Communication partners

Memorandum of Understanding